Demonstrates neuroprotective effects of Ficus deltoidea on cognitive function in an Alzheimer’s disease model, implying therapeutic potential.
Alzheimer’s disease (AD)–related cognitive impairment is characterized by progressive hippocampal dysfunction, neuronal vulnerability, and cholinergic imbalance. Ficus deltoidea (FD), a flavonoid-rich medicinal plant traditionally used in Southeast Asia, has demonstrated antioxidant and neuroprotective properties; however, its effects on hippocampal subregional integrity and cholinergic modulation in AD–like models remain insufficiently characterized. Male Wistar rats were subjected to D-galactose and aluminium chloride (AlCl 3 )–induced neurodegeneration to model AD–like cognitive impairment. FD ethanol extract (50, 100, and 200 mg/kg) was administered orally for 70 days. Recognition memory was evaluated using the novel object recognition (NOR) test, hippocampal dentate gyrus morphology was assessed via hematoxylin and eosin (H&E) staining, and acetylcholinesterase (AChE) levels in the hippocampus were quantified using enzyme-linked immunosorbent assay (ELISA). FD treatment significantly improved recognition memory performance during the retention phase and increased discrimination index values compared with untreated AD-like rats. Histological analysis revealed preservation of dentate gyrus granule cell morphology in FD-treated groups, while biochemical analysis demonstrated a significant reduction in hippocampal AChE levels. Notably, the most pronounced effects were observed at lower FD doses, suggesting a non-linear dose–response relationship. Collectively, these findings suggest that FD exhibits neuroprotective and anticholinesterase effects that may support cognitive function in a chemically induced AD–like model. Nevertheless, further studies incorporating amyloid- and tau-related pathology, synaptic and oxidative stress markers, and direct assessment of cholinergic neurotransmission are warranted to clarify its mechanistic and translational relevance. • Ficus deltoidea (FD) preserves dentate gyrus microarchitecture in an Alzheimer’s disease–like model • FD significantly improves recognition memory and discrimination index • FD reduces hippocampal acetylcholinesterase, indicating cholinergic modulation • Neuroprotective effects exhibit a non-linear dose–response (hormetic pattern) • Findings support FD as a potential multi-target therapy for hippocampal neurodegeneration
No takes yet. Share an insight, caveat, or question.
Usman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: